New hope for arthritis patients: long-term safety trial launched
NCT ID NCT06887127
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study looks at the long-term safety and effectiveness of the drug TLL-018 in people with rheumatoid arthritis who have already finished a previous trial. About 350 adults aged 18 to 75 will take part. The goal is to see how well the drug controls arthritis symptoms over time and what side effects may occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.